Maharashtra FDA cancelled Cipla Pharma’s Pune unit licence over serious violations involving Reactin Plus Tablets. Inspectors found medicines stored on floors, stock record mismatches and poor handling of expired drugs. The FDA flagged unauthorised packaging claims and incomplete recall compliance, warning that drug safety violations will face strict action.
Telangana
FDA Cancels Cipla Pune Unit’s Drug Sale Licence
